TEST LIST
TEST LIST
TEST LIST
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Analysis Method Reference range Requirement Comments<br />
(t-PA) P: Please ask for special tubes.<br />
Indicate therapy with anticoagulants<br />
or fibrinolytic substances.<br />
tissue-type Plasminogen Activator<br />
(t-PA)<br />
Titanium<br />
Page 128<br />
EIA 1.3 - 10.4 ng/ml<br />
AAS < 7.7 µg/l<br />
Tizanidine LC/MS max. 4 - 16 µg/l*<br />
Tobramycin<br />
Tocainide<br />
Tolazamide<br />
Tolazamide<br />
Toluene<br />
FPIA therapeutic trough 0.5 - 2.0 mg/l<br />
therapeutic peak 5.0 - 10.0 mg/l<br />
toxic<br />
therapeutic trough > 2.0 mg/l<br />
therapeutic peak > 10.0 mg/l<br />
HPLC therapeutic range 4.0 - 10.0 mg/l<br />
toxic > 25.0 mg/l<br />
citrate-plasma (1:10) 2 ml<br />
serum 2 ml<br />
EDTA-blood 2 ml<br />
urine 5 ml<br />
serum 1 ml<br />
serum 2 ml<br />
serum 2 ml<br />
LC/MS serum 1 ml<br />
LC/MS therapeutic range 40 - 200 mg/l<br />
urine 10 ml<br />
serum 1 ml<br />
urine 10 ml<br />
GC/MS blood 2 ml<br />
P: please call or write an eMail:<br />
info@mlhb.de<br />
urine 10 ml<br />
Biological half-life: ca. 6 hrs.